BSEIndia
      Close  
NOTICES
Notice No.   20250801-65   Notice Date   01 Aug 2025
Category   Company related   Segment   Equity
Subject   Clarifications received from the companies
Attachments   Reply.zip ;
Content

The Exchange, in order to verify certain news articles appearing in the various newspapers/ websites/ television channels and also to inform the members / investors with regard to the accuracy of the news articles, had sought clarification from the following company. Reply received from them is attached.

1.      Sun Pharmaceutical Industries Ltd (Scrip Code: 524715): https://www.moneycontrol.com

2.      Aurobindo Pharma Ltd (Scrip Code: 524804): https://www.moneycontrol.com

3.      Gland Pharma Ltd (Scrip Code: 543245): https://www.moneycontrol.com

4.      Cipla Ltd (Scrip Code: 500087): https://www.moneycontrol.com

5.      Granules India Ltd (Scrip Code: 532482): https://www.moneycontrol.com

6.      Lupin Ltd (Scrip Code: 500257): https://www.moneycontrol.com

For & On behalf of BSE Ltd

Darshan Arwade

Niraj Angur

Assistant Vice President

Assistant Vice President

Surveillance

Surveillance


01st August 2025